Status:
ACTIVE_NOT_RECRUITING
Initial Correction Keratoconus
Lead Sponsor:
University of Illinois at Chicago
Conditions:
Keratoconus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Keratoconus is a non-inflammatory, progressive disease in which corneal irregularity increases. As the condition develops, more advanced forms of optical correction are needed to improve vision for pa...
Detailed Description
While both corneal gas permeable and scleral lenses have been show to improve visual acuity in individuals with keratoconus, it has yet to be determined if one option has superior comfort and overall ...
Eligibility Criteria
Inclusion
- Diagnosis of keratoconus
- Available baseline corneal topography and pachymetry
- Amsler-Krumeich keratoconus classification9 of stage 1
Exclusion
- No prior corneal transplantation or INTACTS
- No prior use of hybrid, corneal or scleral gas permeable lenses
- Presence of corneal scarring.
Key Trial Info
Start Date :
July 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04918316
Start Date
July 23 2021
End Date
September 1 2025
Last Update
January 22 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago Eye and Ear Infirmary
Chicago, Illinois, United States, 60612
2
Illinois Eye Institute
Chicago, Illinois, United States, 60616
3
Mayo Clinic
Rochester, Minnesota, United States, 55905
4
The Ohio State University College of Optometry
Columbus, Ohio, United States, 43210